蔚藍鋰芯(002245.SZ):子公司與中科海鈉簽署戰略合作協議
格隆匯12月12日丨蔚藍鋰芯(002245.SZ)公佈,公司全資子公司江蘇天鵬電源有限公司(簡稱“天鵬電源”或“甲方”)近期與溧陽中科海鈉科技有限責任公司(簡稱“中科海鈉”或“乙方”)簽署了關於“圓柱鈉離子電池聯合開發、量產、應用推廣和迭代開發”的《戰略合作協議》。
甲乙雙方發揮各自優勢,合作進行圓柱鈉離子電池聯合開發、量產、應用推廣和迭代開發。雙方以約定的產品開發為載體,組建合作團隊、調研討論圓柱鈉離子電池市場應用方向、產品形態和技術規格,共同實施產品開發過程。雙方以驗證和改善鈉離子電池材料性能和成本、優化鈉離子電池設計和性能、尋找最優的產品製造工藝、充分發揮鈉離子電池的市場競爭力為共同目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.